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About This Policy Brief:
This is the second in a periodic series of briefs focusing on key policy issues 
related to childhood asthma.  This Policy Brief series is supported by a grant from 
the Merck Childhood Asthma Network, Inc., and by a major gift from the RCHN 
Community Health Foundation to support the Geiger Gibson/RCHN Community 




Childhood asthma is a serious and costly chronic disease that burdens children and 
families as well as the health care systems that serve them. A key element to 
improving asthma outcomes is access to timely and useful data that can improve the 
quality of care and inform programs and policies to best serve those communities 
most burdened by asthma. This Policy Brief examines the nation’s data collection 
framework for childhood asthma and considers steps that might be taken to 
strengthen it, including the development, collection and refinement of community-
level data to inform local health care systems. Through a review of the public health 
surveillance system  related to childhood asthma, including a specific look at existing 
asthma data, this brief lays out the challenges to the current system and identifies  
opportunities to develop responsive and timely data collection, monitoring and 
surveillance systems, harnessing health information technology (HIT) applications to  
address the many challenges of childhood asthma. This brief includes 
recommendations for improvements in public health reporting systems including 
standardization of measures and a focus on the development of real-time local 
surveillance and mapping technologies to best inform communities working to lessen 
their childhood asthma burden.  
   3
Introduction 
 
This Policy Brief examines the challenges and opportunities that lie ahead in 
developing a community-level information system that is essential to meeting the 
health and health care challenges of childhood asthma. Complete, integrated 
information - about the community-level presence of asthma, its community impact, 
and the performance of local health care systems in alleviating the burden of illness – 
is essential in order to transform the health, social, and economic outcomes associated 
with serious and chronic illness. 
 
No chronic condition better illustrates the importance of health information than 
childhood asthma.  A widespread condition – and one that strikes certain communities 
particularly hard – asthma can be identified, treated, and well managed under 
evidence-informed guidelines and with strong parental involvement, even as broader 
public health efforts are undertaken to prevent it.  Where asthma is poorly managed, 
its adverse impact is felt community-wide, in increased  health costs, lost school days 
and work time, and most importantly, needless childhood illness and at times, death. 
In 2007 alone, asthma cost the United States an estimated $56 billion (2009 dollars) in 
direct expenditures, with productivity losses due to mortality and morbidity costs 
accounting for nearly $4.5 billion.1 Among all conditions for which children are 
hospitalized, asthma is considered the most avoidable.  In 2008 alone, the Medicaid 
program experienced an estimated $582 million in costs related to hospital discharges 
for children with asthma.2 The Centers for Medicare and Medicaid Services (CMS) 
recently identified more comprehensive asthma management as a major opportunity 
for reducing Medicaid program costs3.  
 
Experts consistently point to information about community incidence, patient access, 
and health care quality and outcomes as fundamental to any meaningful effort to 
improve the quality of care, promote population health, and control the growth of 
health care costs. 4 In its 2011 Report to Congress on a National Strategy for Quality 
                                                 
1 Barnett, SBL, Nurmagambetov TA. Costs of Asthma in the United States: 2002-2007. J Allergy Clin 
Immunol. 2011; 127:145-52.   
2 GW analysis of 2008 HCUP data 
3 Letter from HHS Secretary Sebelius to State Governors. February 3, 2011. 
http://www.hhs.gov/news/press/2011pres/01/20110203c.html. Accessed April 20, 2011 
4 76 Fed. Reg. 19528 (April 7. 2011). These three aims were most recently discussed in the 
Administration’s proposed rules governing accountable care organizations. ; Kenney GM, Ruhter J, 
Selden TM. Containing Costs and Improving Care for Children in Medicaid and CHI.  Health Affairs. 2009; 
1025-36.; Wagner, EH, Glasgow RE, Davis C, et al. Quality Improvement in Chronic Illness Care: A 
Collaborative Approach. Journal of Quality Improvement. 2001; 27(2): 63-80;   Mangione-Smith R, 
DeCristofaro AH, Setodji CM et al.  The Quality of Ambulatory Care Delivered to Children in the United 
States. N Eng J Med.2007; 357(15):1515-23 ; Hoppin P. et al. Investing in Best Practices for Asthma: A 
Business Case. August 2010 Update. Asthma Regional Council, 2010; Kattan M, Stears SC, Crain EF, et al. 
Cost-Effectiveness of a Home-Based Environmental Intervention for Inner-City Children with Asthma. J 
Asthma and Clin Immunol. 2005; 116:1058-63; Krieger, J, Takaro TK, Song L, Beaudet N, Edwards K.  A 
Randomized Controlled Trial of Asthma Self-Management Support Comparing Clinic-Based Nurses and 
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Improvement in Health Care,5 the Administration highlighted this link between 
evidence on the one hand and health care and population health improvement on the 
other, emphasizing that a central aim of the Strategy was to “improve the health of the 
U.S. population by supporting proven interventions to address behavioral, social, and 
environmental determinants of health in addition to delivering higher-quality care.”6    
 
This Policy Brief examines the nation’s data collection framework for childhood 
asthma and considers steps that might be taken to strengthen it, with the objective of 
improving health care outcomes and providing a model for the effective community 
based and data-informed management of asthma and other chronic conditions.  
 
Asthma:  A Key Test of the Power and Capabilities of Health Information  
 
There is no stronger example than childhood asthma of a costly and disabling health 
condition that strikes individual children and disproportionately burdens certain 
populations, especially children at elevated risk for disparities in health and health 
care. While asthma is not an infectious disease like measles, in some ways it might as 
well be.  Childhood asthma is more than a patient-specific health problem; as 
underscored by local area studies, asthma can impact entire rural and urban 
communities in which elevated poverty, economic and social stressors, and housing 
and environmental risks make life less safe for children7.  National estimates and 
specialized studies indicate that asthma strikes nearly one in every 10 children and 
one in 7 low income children8.  Children who are members of certain racial and ethnic 
minority groups experience the greatest impact.  Asthma affects approximately one in 
                                                                                                                                                 
In-Home Community Health Workers. Arch Pediatr Adolesc Med. 2009; 163(2): 141-149; Krieger JW, 
Takaro TK, Song L, Weaver M. The Seattle-King County Healthy Homes project: A Randomized, 
Controlled Trial of a Community Health Worker Intervention to Decrease Exposure to Indoor Asthma 
Triggers. Am J Public Health. 2005; 95(4): 652-659. 
5 http://www.healthcare.gov/center/reports/quality03212011a.html 
6 National Strategy to for Quality Improvement in Health Care, 
http://www.healthcare.gov/center/reports/quality03212011a.html#na (Accessed April 20, 2011) 
7 Sandel M, Wright RJ. When home is where the stress is: expanding the dimensions of housing that 
influence asthma morbidity. Arch Dis Child. 2006; 91:942-948; Williams DR, Sternthal M, Wright R. Social 
Determinants: Taking the Social Context of Asthma Seriously. Pediatrics. 2009;123: S174-S184; Rauh VA, 
Chew GR. Deteriorated housing contributes to high cockroach allergen levels in inner-city households. 
Environ Health Perspect. 2002; 110 (suppl 2):323-7; Wright RJ, Mitchell H, Visness CM et al. Community 
violence and asthma morbidity: the Inner-City Asthma Study. Am J Public Health. 2004; 94:625-32; 
Lapnear BP, Aligne CA, Auinger P, Weitzman M, Byrd RS.  Residential Exposures Associated with Asthma 
in US Children.  Pediatrics.  2001: 107: 505-511;  
8 Vital Signs: Asthma Prevalence, Disease Characteristics, and Self-Management Education- United 
States, 2001-2009/. CDC MMWR Early Release May 3, 2011.;  Akinbami LJ, Moorman JE,  Liu X. Asthma 
Prevalence, Health Care Use, and Mortality” United States, 2005-2009. National Health Statistics Reports. 
No. 32. January 2011.; Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: 
National Health Interview Survey, 2009. National Center for Health Statistics. Vital Health Stat 10(247). 
2010. 
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6 non-Hispanic black children and one in 5 children of Puerto Rican heritage.9  
Community-based health care safety net providers such as community health centers 
report childhood asthma prevalence at double the national norm. 
 
In short, asthma is both an individual condition and a broader indicator of community 
health.  Real-time information about how asthma affects both patients and 
populations is   thus extremely valuable. All pediatric health care providers should be 
knowledgeable about and supported to undertake high quality childhood asthma 
management, but certain providers need to be particularly well equipped and 
integrated into broader public health efforts that aim to attack asthma’s root causes.  It 
is essential to understand in which communities or neighborhoods – both urban and 
rural – asthma levels are particularly elevated. Payers and public health authorities 
need ongoing information to measure the quality of health system performance and 
identify communities in which efforts either are succeeding or need to be modified or 
intensified. Producing and using information about childhood asthma thus becomes a 
bellwether for the nation’s health information system more broadly.   
 
This challenge – to produce integrated, real-time, community-level information about 
community and patient health and health care - requires linking disease incidence and 
prevalence measures from numerous sources with clinical information.  Together this 
information allows public health experts and payers to map the condition’s impact, 
support health care providers, report on clinical and programmatic outcomes and 
target resources. It is this ability to analyze and use patient- and community-level 
information in real time that will stand as the real breakthrough in the nation’s health 
system.   
 
One important element of health information is the nation’s public health surveillance 
system. Public health experts define surveillance as the systematic collection, analysis, 
and evaluation of data. These data, in turn, are used to inform public health programs 
and policies aimed at reducing morbidity and mortality.10 Good surveillance depends 
on the collection of certain types of information.  One type is information about 
specific demographic characteristics of individuals affected by a health condition. 
Another is information about which patients are receiving treatment, the types of 
treatment they are receiving in relation to evidence-informed standards of care, and 
the health outcomes of effective treatment as measured by indicators of health such 
as reductions in the need for hospital care and in lost school and work days.  
Compiling such information about childhood asthma requires the ability to collect and 
analyze evidence from many sources such as schools, hospitals, pharmacies, clinics 
and private physician practices, and parent surveys.  Some information, such as health 
care utilization data, might be collected continuously. Other information, such as 
                                                 
9 Vital Signs: Asthma Prevalence, Disease Characteristics, and Self-Management Education- United States, 2001-
2009/. CDC MMWR Early Release May 3, 2011.;Akinbami L, Moorman JE, Garbe PL,  et al. Status of Childhood 
Asthma in the United States, 1980-2007.  Pediatrics.  2009; Vol 123, Supplement 3, S131. 
10 CDC.Updated Guidelines for Evaluating Public Health Surveillance Systems. MMWR. 2001, 50(1-35). 
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surveys of parents, might be collected periodically.  All data need to be collected over 
time so that researchers can measure trends, target policies, programs and services as 
conditions change, evaluate the longer-term effectiveness of health and health care 
interventions, and formulate broader public health policies aimed at reducing the 
incidence and prevalence of illness. 
 
The Current State of Childhood Asthma Information and Surveillance 
 
Valid population-specific data about the diseases that affect children and families 
helps stakeholders to understand the needs of a community and how to appropriately 
direct resources and interventions to address those needs.11 Under the Centers for 
Disease Control and Prevention (CDC) guidelines, states have broad latitude to define 
which conditions they monitor and the evidence that monitoring systems rely on.  
Furthermore, federal funding to help support surveillance activities is limited.  In 2010, 
only twelve states treated asthma of any type, including occupational asthma, as a 
reportable condition.12  Because of the limits of Congressional funding, CDC funding 
for states is insufficient to finance asthma monitoring in all states. Currently, CDC grant 
conditions establish only minimal standards for  childhood asthma information 
collection and reporting at the community level, focused on  the characteristics of the 
communities and populations affected, the rate of health care utilization services that 
are indicative of uncontrolled asthma (such as hospitalization and emergency 
department use), the impact of asthma on communities of different population size, 
and the proportion of children receiving evidence-based asthma management known 
to be effective.  While other sources support data collection  – in particular the federal 
investment in electronic health records (EHRs) - most  of these applications have not 
yet been fully implemented, and policies related to the exchange of health 
information among public health systems, social service and education agencies, 
hospitals, physicians, and pharmacies, are just beginning to be formulated.  
 
Several discrete data collection efforts provide valuable information about childhood 
asthma at the national level. Through its National Center for Health Statistics, CDC 
conducts a variety of national surveys (see Appendix I) that function as surveillance 
tools for monitoring health, including questions related to asthma. The Health 
Resources and Services Administration (HRSA), which oversees the community health 
centers program, has since 1996 required health centers to report asthma outcomes 
among their patients, with additional asthma measures that include pediatric patients 
as part of the HRSA Disparities Collaborative in 2005-2006.13 These data are available 
                                                 
11 Brown CM, Anderson HA, Etzel RA. Asthma: The states’ challenge. Public Health Reports. 1997; 
112(3):198-205. ; Levy BS. Toward a holistic approach to public health surveillance. American Journal of 
Public Health. 1996; 86:624-625.;  Boss PL, Kreutzer RA, Luttinger D et al. The Public Health Surveillance 
of Asthma. Journal of Asthma. 2001; 38(1):83-89. 
12 Council of State and Territorial Epidemiologists.  State Reportable Conditions Query. 
http://www.cste.org/izenda/ReportViewer.aspx?rn=Condition+All&p1value=2010&p2value=Asthma 
13 Personal communication with HRSA. November 16, 2010. ; There is a proposed asthma measure, for adults and 
children about pharmacologic therapy for CY 2011 UDS reporting. Proposed measure:  
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from all federally funded health centers and offer one of the best ongoing sources of 
information about community-level asthma through the lens of more than 1,200 
health centers operating in over 8,000 sites.   
 
Medicaid and the Children's Health Insurance Program (CHIP), two Federal programs 
which together provide coverage for one in three U.S, children, could be a rich source 
of data on pediatric asthma. However, while the CMS oversees the performance of 
both programs, utilization and claims data are not centrally maintained or analyzed. 
State Medicaid programs are not expected to compile and report such information for 
states and communities.  The Title V Maternal and Child Health Block Grant program, 
which is administered by HRSA, similarly provides no ongoing information about 
community and state-level prevalence of childhood asthma or the proportion of 
children receiving treatment.  Under HRSA requirements, Title V programs must report 
certain state-level child health indicators (see Appendix I), but asthma is not included. 
 
In addition to the federally supported data collection and reporting systems described 
above are the data system’s developed- in part through federal investments- for 
public and private payers.  Childhood asthma has become a focus of quality 
measurement and improvement in the payer community; along the way, much 
information has been collected that, in turn, could be harnessed for broader clinical 
and systems improvement. For example, twenty-seven state Medicaid and CHIP 
programs use asthma measures to monitor the quality of managed care plans.14  
CHIPRA also has a core measure set that includes one asthma health care utilization 
measure,15 although it is voluntary for state Medicaid and CHIP programs.16  CMS has 
begun compiling reports of state data from External Quality Review Organization 
(EQRO) efforts that include asthma as part of their quality improvement work.  Among 
private payers, performance on childhood asthma measures is also a common focus of 
quality clinical monitoring.  
 
In the U.S. public health system, it is generally the responsibility of states, working 
under broad federal guidelines, to collect and analyze public health information, 
including disease surveillance data, as key components of population health 
monitoring and promotion. Certain conditions, particularly infectious diseases such as 
sexually transmitted diseases, HIV, and influenza, are considered reportable conditions 
by virtually all states and their reporting is incentivized by financial and technical 
support from the CDC.  By contrast, federal and state data collection and reporting 
                                                                                                                                                 
Asthma – Pharmacological therapy: Percentage of patients age 5 to 40 years with a diagnosis of persistent 
asthma (either mild, moderate, or severe) who were prescribed either the preferred long term control medication 
(inhaled corticosteroid) or an acceptable alternative pharmacological therapy (leukotrene modifiers, cromolyn 
sodium, nedocromil sodium, or sustained released methylxanthines) during the current year.  
14 Medicaid Managed Care Quality Benchmarking Project. National Committee for Quality Assurance. 
Prepared for Centers for Medicare and Medicaid Services. August 23, 2010. 
https://www.cms.gov/MedicaidCHIPQualPrac/Downloads/NCQAMBench.pdf 
15 CHIPRA measure:  Annual number of asthma patients (>1 year old) with >1 asthma related ER visit (S/AL Medicaid 
Program) 
16 AHRQ. CHIPRA Health Care Quality Measurement and Improvement Activities. http://www.ahrq.gov/chipra/ 
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policies are less active and uniform for other conditions such as childhood asthma, 
despite their high prevalence and costs to health and health care. Consequently, 
though conforming to current federal guidance, state-level surveillance and reporting 
is not standardized for asthma.  
 
As part of the public health information system, the CDC has identified six basic 
elements of an effective disease surveillance system for any health condition (Figure 
1).  
 
FIGURE 1. CDC’s Six Basic Elements of an Effective Disease 
Surveillance System 
 
1) Prevalence  
2) Use of scheduled office visits to treat the condition*  
3) Use of unscheduled office visits to treat the condition * 
4) Emergency department (ED) visits* 




* These elements are also used as indirect indicators of quality of care 
furnished to children with asthma, with high ED use and inpatient admissions 
suggestive of care that is of poorer quality and does not effectively manage 
the condition in a lower cost and less burdened ambulatory care setting. 
 
 
Through its National Asthma Control Program (described below), the CDC has also 
identified 6 key elements in high quality asthma surveillance, displayed in Figure 2. 
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FIGURE 2. The Asthma Surveillance Pyramid
Source: Centers for Disease Control and Prevention. “A Public Health Reponse to Asthma,” PHTN 
Satellite Broadcast, Course Materials 2001. 
 
 
Despite the recognized policy importance of a robust, disease-specific surveillance 
system, an evaluation of current practice reveals fragmentation that has real 
implications for the nation’s health.  
 
What Childhood Asthma Monitoring Might Look Like 
 
Obtaining more robust and useful information about childhood asthma involves 
updating traditional ideas about surveillance to include focused, strategic efforts to 
locate, target, and assist the most significantly burdened communities. Certain 
emerging health information technologies hold major promise to supplement the 
availability of data currently available through public health surveillance and 
information culled from provider activities and claims.  Asthmapolis, an asthma inhaler 
tracking program, is a prime example of innovative surveillance technology- put to 
work for the public health system (Figure 3).  Applications like these can be employed 
to gather, analyze, and present information about childhood asthma, and are central 
to a modern health care system.  Innovative surveillance tools, including geomapping 
using real-time data, can be used to collect a range of data including hospital and ED 
utilization data, the number and location of children under treatment, and measures 
of treatment in relation to evidence-informed standards published by the National 
Institutes of Health (NIH).17  These data can help identify the presence of asthma, the 
effectiveness of appropriate treatment, and the highest-risk and costliest patients who 
                                                 
17 National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 
3: Guideline for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 2007 
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need the most intensive intervention to help them manage and control their asthma.18 
 
 
Tools applied to assess the presence of other health conditions and the effectiveness 
of treatment hold promise for childhood asthma.  One example is focused geo-
mapping such as the “ResistanceMap,”19 an application that tracks the presence of 
antibiotic-resistant superbugs over time.  “ResistanceMap," which includes 
community-level tracking capabilities, allows users to pinpoint states and locales 
where specific superbugs are most prevalent and identify changes over time.  By 
providing geographic information system (GIS) functionality, "ResistanceMap" can 
help communities plan and carry out quality improvement efforts, public education 
and awareness campaigns, while enabling public health officials to work with targeted 
health care providers to strengthen treatment and management regimens. 
FIGURE 3. Asthmapolis 
 
Asthmapolis is an asthma tracking system that aims to improve the 
management of asthma through the use of GPS enabled inhalers. 
Medication sensors determine the time and location when an 
inhaler is used and send that information to a server where 
anonymous and voluntarily shared data is aggregated for 
scientists and public health workers.  
 
Asthmapolis is also available in a mobile application program that 
allows individuals to map and track their asthma symptoms, 
triggers and medication use, monitor their trends over time, and 
identify locations that exacerbate their asthma symptoms.  
 
More information is available at: http://asthmapolis.com/ 
 
"ResistanceMap" is designed to track infectious diseases, but there are examples of 
similar GIS tools being used to address serious public health conditions such as 
obesity. For example, the United States Department of Agriculture (USDA) maintains a 
Food Environment Atlas that creates state-level maps highlighting key indicators of 
obesity, including, among other measures, food access in restaurants and grocery 
stores, food assistance and food taxes, and physical activity levels.20  This information 
allows families to understand their risks of exposure to a public health threat while 
                                                 
18 Ibid.  
19 ResistanceMap. http://www.cddep.org/resistancemap. Extending the Cure, project of the RWJF’s 
Pioneer Portfolio.  
20 USDA Food Environment Atlas. http://www.ers.usda.gov/foodatlas/ 
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empowering better practice and policymaking decisions at community levels.  The 
software also allows users to identify threats at a county level, thereby providing a 
more precise lens through which to view the risks associated with obesity.  Given what 
is known and documented about the seasonality of asthma attacks and 
hospitalizations, tracking seasonality and  environmental pollutants or measures could 
be done in real time and mapped to local jurisdictions to identify risks in those 
communities.  A comprehensive asthma mapping tool could literally provide a picture 
of what environmental risks look like in different communities during peak asthma 
periods, and help focus abatement efforts.  
 
What Current State-Level Data Produced Through CDC’s National Asthma 
Control Program Tell Us About Childhood Asthma 
 
In 1999, the CDC launched the National Asthma Control Program as a means of 
responding to a significant increase in asthma prevalence at the national level during 
the 1980s and 1990s.  The purpose of the program is to systematically understand the 
asthma burden and to allow public health officials and policymakers to get answers to 
key questions, including the total number of people with asthma, the number of cases 
that occur over time, the distribution of the disease burden among subgroups of the 
population, the level of case control, and the cost of asthma.21 
 
The National Asthma Control Program funds states, cities, and school programs.  CDC 
funding is used to assist in local control efforts and improve state and local 
surveillance activities.  Surveillance expenditures account for 13% of funded activities, 
while 18% goes for health interventions, and 69%, to CDC “partnership” collaborations 
among the CDC, state health departments, the Environmental Protection Agency 
(EPA), and private organizations focusing on asthma prevention and control (Figure 4, 
below).22 
                                                 
21 CDC, Breathing Easier, 2009 
22 CDC, Breathing Easier, 2009 
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FIGURE 4. CDC’s National Asthma Control Program Components 
and Share of the Budget
Source: CDC, Breathing Easier, 2009.
 
The National Asthma Control Program has grown from a total expenditure of $800,000 
in 1999 to $13.3 million in 2007. That year, awards were made to 34 states, the District 
of Columbia and Puerto Rico, meaning that not all states receive support for asthma-
related information development activities.23 As of 2010, CDC funds were sufficient to 
support grants to only 36 jurisdictions.  (See Figure 5 for jurisdictions receiving 
funding as of 2010) 
                                                 
23 CDC, Breathing Easier, 2009 
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FIGURE 5.  Thirty-Four States, Washington, DC and Puerto Rico Have 
CDC-Funded Asthma Control Programs. 
Source: CDC, Breathing Easier, 2010
 
The Program’s aim is to track the burden of asthma as well as efforts to target and 
reduce that burden.24 As part of this program, jurisdictions receiving funding are 
expected to periodically release an asthma burden report detailing the impact of 
asthma in their area. CDC guidelines allow considerable variation in the reportable 
measures and data collection approach that informs these burden reports, including 
the survey instruments used to conduct measurement, the specificity of information 
reported, the techniques used to gather and assess the information, and the time 
periods over which measurement occurs.  
 
In order to build a more complete picture of what is known about childhood asthma, 
the research team at George Washington University's Department of Health Policy 
undertook an effort to analyze all state asthma burden reports available as of 
November 2010 on each state’s website.  A total of 36 state reports were available as 
of that date.  The research team examined the content of the burden reports, the types 
of measures reported and the comparability of the information across the states.  To 
better understand both the variation in reported information as well as the commonly 
reported elements, we reviewed the reports using  CDC’s six-dimensional approach to 
surveillance: (1) prevalence and severity; (2) scheduled office visits; (3) unscheduled 
office visits; (4) emergency room visits; (5) hospital admissions; and (6) deaths. To 
streamline the results, we categorized these elements into five domains: (1) 
prevalence; (2) health care utilization; (3) morbidity, (4) disease management, and (5) 
cost and coverage.  (See Appendix II – List of variables collected at the state level)  
 
                                                 
24 CDC National Asthma Control Program. Guide for State Agencies in the Development of Asthma 
Programs. December 2003. http://www.cdc.gov/asthma/nacp.htm 
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Findings 
 
Overall status of state asthma surveillance 
 
All 36 states reported asthma prevalence measures.  However, only one-third reported 
on asthma costs or the extent of health insurance coverage among children with 
asthma, and only slightly more than half reported on measures of morbidity such as 













FIGURE 6. Number of States/Jurisdictions Reporting Data on Asthma, 
by Measure Sub-Category, 2010
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
 
Prevalence (n=36; 100%) 
 
Accurate measures of the prevalence of asthma, both lifetime and current, are the 
cornerstone of understanding disease burden as well as trends in the population. All 
36 states reported on prevalence, using a total of 23 different measures. Thirty states 
reported on measures of current asthma prevalence in children, 28 states reported on 
measures of prevalence by family or child demographics, and 27 states reported on 
measures of lifetime asthma prevalence in children. Fifteen states reported on 
prevalence measures by insurance status; of those, eight reported this for Medicaid 








































FIGURE 7. Specific Prevalence Measures Among 36 State Asthma 
Burden Reports, 2010
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
 
Health Care Utilization (n=35) 
 
Health care utilization measures, which are available through hospital discharge 
records and national surveys, are key indicators of disease severity, management, and 
control as well as access to different types of service in a community (e.g., ambulatory 
care, ED care).  Thirty-five states reported on at least one health care utilization 
measure and a total of 21 different measures of health care utilization were reported. 
Notably, the measurement system included only one measure on routine 
office/outpatient visits (Figure 8).  
 












Atleast 1 Health Care Utilization
Measure Reported








FIGURE 8. Health Care Utilization Reporting Among 36 State 
Asthma Burden Reports, 2010
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
 
Typical utilization measures include hospitalization and ED encounter rates. These 
rates can indicate a number of trends, such as poorly controlled asthma as well as 
inadequate access to primary and ambulatory care, reflecting a dearth of providers or 
lack of access to those providers by community members. Nine states reported on 
total ED utilization rates among children with asthma, while 11 states reported on 
total hospitalization rates among children with asthma. Fifteen states reported on ED 
measures by age group among children with asthma, while 25 states reported on 
hospitalization measures stratified by age group of children with asthma (Figure 9).  
 










































Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
FIGURE 9. Specific Health Care Utilization Measures Among 35 




Morbidity measures, including asthma symptoms, activity limitations, missed school, 
and the presence of asthma attacks represent important measures of symptom 
severity and control. These indicators can also provide insight into  the asthma burden 
experienced by  children, families, and schools25 and help inform more effective 
patient-focused education  efforts, which have been shown to help reduce asthma 
morbidity.26 
 
Twenty-one states reported on at least one morbidity measure, while a total of 29 
different morbidity measures were reported across all states. These included 13 
measures related to symptoms, seven related to activity limitations, and five related to 
attacks (Figure 10).  
                                                 
25 Diette GB, Markson LM, Skinner EA, Nguyen TTH, Algatt-Bergstrom P, Wu AW.  Nocturnal Asthma in 
Children Affects School Attendance, School Performance, and Parents’ Work Attendance.  Archives of 
Pediatric and Adolescent Medicine. 2000;154:923-928.; Glazebrook C, McPherson AC, Macdonald IA, Swift 
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and Panic Attacks Among Youth in the Community. Journal of Asthma. 2003;40(2):139–145. 
26 Coffman JM, Cabana MD, Halpin HA, Yelin EH. Effects of Asthma Education on Children’s Use of Acute 
Care Services: A Meta-Analysis. Pediatrics. 2008; 121:575-596. ; Guevara JP, Wolf FM, Grum CM, Clark NM. 
Effects of Educational Interventions for Self-Management of Asthma in Children and Adolescents: 
Systematic Review and Meta-Analysis. BMJ. 2003; 326:1308-1309.; Martinez FD. Managing Childhood 
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FIGURE 10. Morbidity Measures Reporting Among 36 State Asthma 
Burden Reports, 2010 
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
 
Morbidity reporting showed great variation, with 13 different measures in use. Asthma 
attacks showed the least variability, perhaps because they represent the most severe 
measure.  Fifteen states reported on seven different activity limitation measures, with 
the most frequently reported measure about children with current asthma being 
















Asthma Symptoms Asthma Attacks Activity Limitations
# of Reporting States # of Related Measures
FIGURE 11. Specific Morbidity Measures Among 21 State Asthma 
Burden Reports, 2010.
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
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Disease Management (n=25) 
 
For children with asthma, comprehensive disease management consists of several 
core elements as identified in evidence-informed guidelines; each involves family and 
other support systems, and each is critical to the success of an effective treatment and 
control regimen. For example, medication use, self-management education, and 
environmental exposure remediation are all central to disease management.  
 
Twenty-five states reported disease management measures that incorporated the 
above- referenced aspects of disease management, including patient-level and 
environmental measures (Figure 12). Of these twenty-five states, thirteen have 
reported on at least one of 39 separate measures that together provide a picture of 
how well asthma is being managed at the patient level. (See Appendix II for list of 
disease management measures). The burden reports also captured information on 
environmental exposures and trigger remediation, which evidence shows are 
correlated with asthma symptoms and attacks. 27 Twelve of these states reported on 
environmental exposures using eight related measures, focusing on both first and 
second-hand smoke exposure to tobacco among children with asthma.  This type of 
exposure has a known causal link to increased asthma prevalence, frequency of 
symptoms, and disease severity.   
 
                                                 
27 Lapnear BP, Aligne CA, Auinger P, Weitzman M, Byrd RS.  Residential Exposures Associated with 
Asthma in US Children.  Pediatrics.  2001: 107: 505-511; Wu F, Takaro TK.  Childhood Asthma and 
Environmental Interventions.  Environ Health Perspect.  2007;115:971–975.; Rosenstreich DL, Eggleston P, 
Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity 
among inner-city children with asthma. New England Journal of Medicine. 1997;336:1356-63; Gent JF, 
Belanger K, Triche EW, Bracken MB, Beckett WS, Leaderer. Association of pediatric asthma severity with 
exposure to common household dust allergens. Environmental Research. 2009. 
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FIGURE 12. Disease Management Reporting Among 36 State 
Asthma Burden Reports, 2010
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
 
Of the 39 patient-level disease management measures, four relate directly to the 
provision of asthma action plans. Fifteen states reported on one of these four 
measures, the most common of which was the percent of children with asthma who 











Medication Use Tobacco Exposure
# of reporting States # of related measures
FIGURE 13. Specific Disease Management Measures Among 
25 State Asthma Burden Reports, 2010.
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Cost and Coverage (n=12) 
 
Ten states reported on the cost of childhood asthma services, using nine measures.  
The most frequently used measure, average charges per asthma hospitalization by 
age, was used by six states.   Despite the importance of insurance in assuring access to 
high quality asthma care, only two states reported on the proportion of children 













Atleast 1 Cost Measure
Reported








FIGURE 14. Cost and Coverage Reporting Among 36 State Asthma 
Burden Reports, 2010.
Source: GW SPHHS Analysis of 36 State Asthma Burden Reports Available as of November 2010
 
Overall reporting  
 
Beyond differences in the frequency of reporting on any particular measure, there is 
significant variability in how and what states report. While the available data provide 
valuable information on asthma trends within individual states, data are not reported 
for a common year, limiting comparability across states. Some categories of data were 
more widely collected and reported, such as prevalence and health care utilization, 
whereas data about cost and coverage and certain aspects of disease management, 
such as environmental assessments or remediation, were less frequently collected and 
reported.  
 
Even where common measures were reported, there was no uniform set of variables 
collected across the funded states. For example, many states collected data about 
asthma action plans but collected slightly different information about the plans or 
asked about them with sufficient variation that they were, in fact, asking different 
questions. Additionally, the states used different measurement ranges, including 
different age ranges and categories for race and ethnicity, as well as years of school 
among middle or high school children and the definition of students in school level 
data. Many states reported school data but some states only reported on certain 
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grades (e.g., sixth, eighth, and tenth grades), thus only representing a small portion of 
all children in that state. Sources of school data were also only for public schools and 
omitted a portion of the child population who are not enrolled or attending a public 
school or are not currently in school.  
 
Several states report data variables that are particularly useful when considering 
asthma from a holistic perspective, such as asthma prevalence by body mass index 
(BMI) (one state) and asthma management (i.e. asking about training on different 
inhalers, medications, and management strategies) (seven states). 
 
Finally, the state asthma reports contain very little sub-state level data, despite the 
known utility of community- and neighborhood-specific data in measuring 
community variation and targeting resources.   
 
Conclusions and Recommendations 
 
This analysis underscores the importance of comprehensive and consistent 
information in effective management of childhood asthma, one of the most 
widespread and costly health conditions faced by children and their families.  Health 
information allows communities, states, and the nation to understand the impact of a 
condition, the populations and communities most affected, and progress in treatment, 
management, and health outcomes.  Our analysis of CDC-supported state asthma 
reporting systems reveals both the absence of comprehensive reporting in all 
jurisdictions as well as a lack of uniformity regarding what measures are reported, how 
key terms are defined for collection and reporting systems, the time period over which 
information is collected, and how information is presented. 
 
There are important reasons to bring particular focus to asthma, as well as reason to 
do so at this particular time. First, basic reporting is in place through important 
periodic national surveys, grants to states for asthma control programs, information 
available through the community health centers program, and the identification of 
childhood asthma management as a reportable  measure for many payers under the 
National Committee for Quality Assurance (NCQA) and other quality measurement 
systems.  This provides a baseline for expanded data collection on the one hand, and 
condition-specific focus on the other.  Further, this is an opportune time to address 
collection of public health information.  A commitment to prevention and public 
health is embodied in the Affordable Care Act, and the tools for technology-enabled 
collection of data at the practice level are in place as a result of the national 
investment in HIT under the American Reinvestment and Recovery Act (ARRA). These 
investments position the nation, over time, to enhance its ability to monitor 
population health and measure the effectiveness of health care. 
 
Extending existing data collection capabilities requires a targeted national asthma 
information initiative, as part of a national focus on effective collection and analysis of 
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health information that takes into account what is known today, the direction in which 
knowledge must move, and what steps are needed to get there.  This effort might 
encompass multiple federal health agencies, state and local public health agencies, 
health care providers now in the HIT adoption stage, and consumers and families.  
 
As part of a targeted national effort, certain types of health information might be 
collected less frequently than today (e.g., every 2-3 years) but with more focus on 
state- and community-level information that can help identify health patterns to 
inform and health care interventions.  While measuring year-to-year changes is ideal, 
the cost of this approach in relation to the expectation of changes over time might 
argue for somewhat less frequent but more robust information. Rather than  annual, 
limited, and highly variable reports from a portion of states, more valuable might be 
bi-annual information from all states that captures information at the county level, 
using harmonized collection and reporting periods, common and clearly defined 
reporting measures, and common measurement and reporting methods that track the 
CDC surveillance framework. Following the establishment of a baseline reporting 
system that contains sufficient information and harmonization to provide a 
comprehensive picture, reporting might be updated periodically. 
 
To create better health information about childhood asthma, the definition of what 
elements are essential to improved outcomes should be reconsidered. Many existing 
clinical performance measurement systems focus narrowly on prescriptions and 
hospitalizations, thereby missing the opportunity to capture data on asthma 
management, including asthma education, case management, and environmental 
remediation efforts or comorbid conditions, such as obesity and depression. In a 
national effort to upgrade information on child health asthma management, it is 
important to consider whether measures of quality need to conform better to 
evidence-informed quality guidelines so that progress toward meeting such standards 
actually can be measured. A more comprehensive set of measures that are more 
clearly articulated and defined could be endorsed by CMS, and as quality of care data 
become available, this information could be added to the state information base 
maintained through the CDC investment. While Medicaid and CHIP represent a 
national starting point, the National Quality Strategy’s emphasis on all-payer 
information means that over time, public health agencies could receive information 
on key measures from all payers.  Potential expanded measures include: 
 
• The percentage of patients evaluated during at least one office visit for 
frequency of daytime and night-time asthma symptoms. (Quality 
measure from National Quality Forum or NQF);    
 
• The percentage of pediatric patients with persistent (mild, moderate, or 
severe), not well controlled, or very poorly controlled asthma who were 
prescribed either the preferred long-term control medication (inhaled 
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corticosteroid) or an acceptable alternative treatment. (Quality measure 
from National Quality Forum or NQF);   
 
• The percentage of children with asthma who have been appropriately 
evaluated for exposure to significant environmental triggers, such as 
environmental tobacco smoke, dust mites, cats, dogs, molds/fungi, or 
cockroaches, either by history of exposure and/or by allergy testing. 
(Quality measure from the HRSA Disparities Collaborative). 
    
As HIT adoption moves forward, it will be increasingly important for states to provide 
more robust information to public health agencies.  Information on childhood asthma 
represents a valuable place to begin such an undertaking, since the basic CDC 
framework for collecting and analyzing such information through the asthma control 
program is in place.  The Health Insurance Portability and Accountability Act (HIPAA)  
Privacy Rule contains an express public health exception that allows public health 
agencies to acquire, aggregate, and de-identify such data in order to create 
information that can inform localities about the proportion of children with asthma 
who receive effective treatment. Health care utilization data on hospital admissions 
and emergency department also would provide insight into utilization patterns of and 
changes over time.  Of particular importance is the enhancement of state to capture 
and report local-area data. Specifications for local reporting and mapping at the zip 
code, neighborhood, or community level would greatly enrich the utility of the 
reported information.   
 
Potential sources of data include the federal investment in state asthma control 
systems with data collection and reporting capabilities, claims data from federal health 
care programs, comparable data collected by private payers that elect to do so, and 
data from other federal initiatives such as the community health centers program and 
grants to states to support maternal and child health activities. These data can be 
supplemented by periodic national surveys, revised and updated to consider new 
information.  
  
Essential to strengthening the public health information system is the use of new tools 
to better capture asthma data that can, in turn, be used by local communities to 
identify and decrease their asthma burden. Existing gaps between clinical systems and 
public health systems need to be bridged; a comprehensive public health information 
network could serve as the connector between clinical and environmental and public 
health data.  Applications such as geomapping can be used to track the burden of 
asthma and guide   appropriate and timely resource deployment.  Existing initiatives 
like the federal Public Health Information Network could be expanded beyond 
communicable disease surveillance to incorporate the exchange of data on asthma 
and other chronic and debilitating conditions. Interoperable solutions are essential 
and merit support – as are further interagency collaborations.  
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Curtailing health care costs while improving the quality of care and the health of 
populations are a “triple aim” for the nation.  Because health care costs and health 
status are driven by myriad conditions, a health information infrastructure is needed 
that can serve the needs of the entire population. 
 
At the same time, all journeys begin with the first step.  With resources already 
invested in child asthma reporting, a sensible step is to marshal the resources that are 
available, in order to develop a framework that can serve as a model and platform for 
other diseases and conditions that merit comparable attention because of the 
potential impact of health information to respond to and address the "triple aim" of 
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